-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on KORU Medical Systems, Raises Price Target to $6

Benzinga·12/17/2025 20:20:31
語音播報
Canaccord Genuity analyst Caitlin Roberts maintains KORU Medical Systems (NASDAQ:KRMD) with a Buy and raises the price target from $5 to $6.